s-nitrosopenicillamine has been researched along with gyy 4137 in 1 studies
| Studies (s-nitrosopenicillamine) | Trials (s-nitrosopenicillamine) | Recent Studies (post-2010) (s-nitrosopenicillamine) | Studies (gyy 4137) | Trials (gyy 4137) | Recent Studies (post-2010) (gyy 4137) |
|---|---|---|---|---|---|
| 19 | 0 | 1 | 157 | 0 | 149 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, A; Cortese-Krott, MM; Feelisch, M; Fernandez, BO; Grman, M; Kelm, M; Mergia, E; Nagy, P; Santos, JL | 1 |
1 other study(ies) available for s-nitrosopenicillamine and gyy 4137
| Article | Year |
|---|---|
Nitrosopersulfide (SSNO(-)) accounts for sustained NO bioactivity of S-nitrosothiols following reaction with sulfide.
Topics: Animals; Cell Line; Cyclic GMP; Guanylate Cyclase; Morpholines; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Organothiophosphorus Compounds; Oxygen Consumption; Rats; Receptors, Cytoplasmic and Nuclear; S-Nitrosothiols; Soluble Guanylyl Cyclase; Sulfides | 2014 |